Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...

In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...

ORLANDO, Fla., June 21, 2024. Today, findings from the Lowering Events in Non-proliferative retinopathy in Scotland (LENS) Trial revealed that...

New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.

A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to...

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorder

Elenolic acid, found in olives, significantly lowers blood sugar and promotes weight loss in obese diabetic mice, paving the way for natural...